About Bryan Oronsky, MD, Ph.D.

2 POSTS 0 COMMENTS

https://www.epicentrx.com

Bryan Oronsky, MD, Ph.D. serves as EpicentRx Chief Development Officer and combines firsthand clinical experience as a physician with 17 years of pharmaceutical development experience that includes considerable time and effort spent on publishing and patenting.

Severe Oral Mucositis: Companies Put Their Money where the Mouth is...

Bryan Oronsky, MD. Ph.D. - September 11, 2023

The Dictatorship of Cancer: How to Topple it in Three –...

Bryan Oronsky, MD. Ph.D. - October 21, 2022

LATEST NEWS

October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection

Danielle Garcia - September 20, 2023

Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy

Jennifer Klarer - September 18, 2023

Understanding the True Impact of Microbiota on Cancer Development and Treatment

Peter Hofland - September 18, 2023

Language Barriers and the Impact on Cancer Care

Peter Hofland - September 16, 2023

Long-term Outcomes of Radiation Techniques for the Treatment of Locally Advanced NSCLC

Peter Hofland - September 12, 2023

Press Releases | Cancer

Sleeplay Recognized for Health Care Standard of Excellence Web Award September 22, 2023
Sleeplay, an online CPAP store committed to providing the next generation with expert guidance and premium CPAP products for improved sleep therapy, is pleased to announce its recent recognition. The company's website, expertly crafted and developed, has received the Health Care Standard...
Extended Reality (XR) Makes Healthcare Training Faster, Easier to Implement, and More Effective, According to HTC VIVE Study September 22, 2023
Nine out of ten healthcare professionals believe that XR enhances their training and empowers them to be more effective at work SEATTLE, Sept. 22, 2023 /PRNewswire-PRWeb/ -- As healthcare organizations look for better ways to train their staff on everything from how to carry out new...
The FSHD Society's September 23 podcast gives voice to thousands fighting FSH muscular dystrophy September 22, 2023
The livestream will feature patients, families and allies who are "walking and rolling" across the U.S. and Canada to raise awareness and funds for the debilitating condition RANDOLPH, Mass., Sept. 22, 2023 /PRNewswire-PRWeb/ -- The FSHD Society announced that this Saturday, September 23,...

Bryan Oronsky, MD. Ph.D.

Severe Oral Mucositis: Companies Put Their Money where the Mouth is...

The Dictatorship of Cancer: How to Topple it in Three –...

LATEST NEWS

October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection

Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy

Understanding the True Impact of Microbiota on Cancer Development and Treatment

Language Barriers and the Impact on Cancer Care

Long-term Outcomes of Radiation Techniques for the Treatment of Locally Advanced NSCLC

October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection

Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy

Understanding the True Impact of Microbiota on Cancer Development and Treatment

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...